fashion -WSS

fashion

author：comprehensive 2025-09-29 19:59:21 - browse：7

Fiona Marshall, president of the Novartis research hub in Cambridge, Mass., speaks Thursday during the STAT Future Summit. STAT

Swiss drugmaker Novartis’ research and development hub has a new name — and a new guiding strategy.

The hub, which is headquartered in Cambridge, Mass., and for years has been known as Novartis Institutes for BioMedical Research, or NIBR, will soon simply be known as Novartis Biomedical Research.

But that’s not the only thing that’s changing, Fiona Marshall, the hub’s president, told a virtual audience Thursday during the 2023 STAT Future Summit. The new name reflects a larger shift by the pharma giant to retool its research strategy — from one driven by the pure pursuit of scientific discovery to a tighter focus on projects likely to yield commercially successful drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Hospitals are piloting generative AI tools as regulators play catch

WSS

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Hospitals are piloting generative AI tools as regulators play catch

Opioid cravings were reduced by anti

A new drug could help frostbite victims avoid its ravages

Why the world’s most expensive drug might be worth the price

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

entertainment

fashion

leisure time

Continuity nursing helped my family in our darkest PICU moments

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Wildfire smoke exposes gaps in outdoor worker protections

Primary care physicians play key roles in Alzheimer's management

The cancer drug shortage isn’t new — and neither are the solutions

FDA's naming rule on biosimilars has undermined competition

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The Readout: Lenmeldy, GLP

Continuity nursing helped my family in our darkest PICU moments

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

hotspot

MD Anderson's Padmanee Sharma responds to research credit suit

Vertex Pharmaceuticals may move headquarters in Boston

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Supreme Court mifepristone arguments center on docs' right to sue

Abortion pill Supreme Court ruling could impact entire drug industry

hotspot

explore

explore

hotspot